Announced details
Cybersecurity, zero-day vulnerability detection, patch or code-fix recommendations for vulnerabilities, and software and source-code verification
The CVSS scores of the detected vulnerabilities were 5.9, 7.5, 7.3 and 8.8. Specific detection rates, reduction rates and other figures are not disclosed.
AGEST identified multiple vulnerabilities in its validation testing. A proof of concept in a customer environment is scheduled to begin in late July 2026, and applications are already closed. The number of companies adopting the platform is not disclosed.
AGEST is jointly developing the platform with the company. AGEST is a subsidiary of DIGITAL HEARTS HOLDINGS Co., Ltd.
A US company. Its location, representative, capitalisation, year founded and business activities are not disclosed.
CVE-2026-28208, CVE-2026-32316, CVE-2026-40034 and CVE-2026-27775. The certification registration numbers and validity periods are not disclosed.
Annual fixed-fee licensing model. The amount is not disclosed.
The impact on revenue and profit is not disclosed.
The company does not address Contract Value.
CVE, ANT-CVD and CVSS. Claude Mythos Preview and Project Glasswing are also mentioned.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Comprehensive autonomous-AI cybersecurity platform “AGEST ZERO SHIELD”, Zero-day vulnerability hunting |
| Counterparty | Lazarus Enterprises, Inc. |
| Counterparty overview | A US company. Its location, representative, capitalisation, year founded and business activities are not disclosed. |
| Relationship with the Company | AGEST is jointly developing the platform with the company. AGEST is a subsidiary of DIGITAL HEARTS HOLDINGS Co., Ltd. |
| Offering price | Annual fixed-fee licensing model. The amount is not disclosed. |
| Contract Date | Not disclosed. The disclosure states that the joint development was announced on 10 June 2026. |
| Launch date | The proof of concept is scheduled to begin in late July 2026. Commercialisation of the first set of functions is scheduled for September 2026. |
| Applicable area | Cybersecurity, zero-day vulnerability detection, patch or code-fix recommendations for vulnerabilities, and software and source-code verification |
| Registration number and expiry date | CVE-2026-28208, CVE-2026-32316, CVE-2026-40034 and CVE-2026-27775. The certification registration numbers and validity periods are not disclosed. |
| Quantitative Effects | The CVSS scores of the detected vulnerabilities were 5.9, 7.5, 7.3 and 8.8. Specific detection rates, reduction rates and other figures are not disclosed. |
| Usage history | AGEST identified multiple vulnerabilities in its validation testing. A proof of concept in a customer environment is scheduled to begin in late July 2026, and applications are already closed. The number of companies adopting the platform is not disclosed. |
| Impact on Business Performance | The impact on revenue and profit is not disclosed. |
| Source | CVE, ANT-CVD and CVSS. Claude Mythos Preview and Project Glasswing are also mentioned. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To address increasingly sophisticated AI-enabled cyberattacks, data-sovereignty concerns arising from the external transmission of source code, the burden of token-based fees, the risk of losing access to AI models, alert fatigue and other issues.